Cargando…
COVID-19 diverse outcomes: Aggravated reinfection, type I interferons and antibodies
SARS-CoV-2 infection intrigued medicine with diverse outcomes ranging from asymptomatic to severe acute respiratory syndrome (SARS) and death. After more than two years of pandemic, reports of reinfection concern researchers and physicists. Here, we will discuss potential mechanisms that can explain...
Autores principales: | Costa Silva, Rafael Cardoso Maciel, Bandeira-Melo, Christianne, Paula Neto, Heitor Afonso, Vale, André Macedo, Travassos, Leonardo Holanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461281/ https://www.ncbi.nlm.nih.gov/pubmed/36105250 http://dx.doi.org/10.1016/j.mehy.2022.110943 |
Ejemplares similares
-
Autophagy: A self-guard against SARS-CoV-2
por: Silva, Rafael Cardoso Maciel Costa, et al.
Publicado: (2022) -
Autophagy Modulators in Coronavirus Diseases: A Double Strike in Viral Burden and Inflammation
por: Silva, Rafael Cardoso Maciel Costa, et al.
Publicado: (2022) -
COVID-19: Is reinfection possible?
por: Costa, Aratã Oliveira Cortez, et al.
Publicado: (2021) -
Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil
por: Bonifácio, Lívia Pimenta, et al.
Publicado: (2020) -
Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis
por: Chen, Yaqin, et al.
Publicado: (2015)